Current Assets
Total Current Assets
Regeneron Pharmaceuticals Total Current Assets increased by 1.0% to $18.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.6%, from $17.57B to $18.21B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 13.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
A higher value relative to current liabilities indicates a strong safety margin for meeting short-term obligations.
Detailed definition
The sum of all assets that are reasonably expected to be converted into cash or consumed within one year. This aggregate...
Peer comparison
High-growth tech companies often maintain high current asset levels to support rapid scaling and R&D needs.
Metric ID:
total_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.34B | $13.78B | $14.01B | $14.31B | $15.53B | $15.43B | $15.88B | $16.91B | $16.92B | $18.63B | $19.48B | $18.87B | $19.08B | $19.33B | $18.66B | $17.57B | $16.86B | $17.98B | $18.02B | $18.21B |
| QoQ Change | — | +3.3% | +1.7% | +2.1% | +8.6% | -0.7% | +3.0% | +6.5% | +0.1% | +10.1% | +4.5% | -3.1% | +1.1% | +1.3% | -3.5% | -5.8% | -4.1% | +6.7% | +0.2% | +1.0% |
| YoY Change | — | — | — | — | +16.4% | +12.0% | +13.3% | +18.2% | +9.0% | +20.8% | +22.6% | +11.6% | +12.8% | +3.7% | -4.2% | -6.9% | -11.6% | -7.0% | -3.4% | +3.6% |
Range$13.34B – $19.48B
CAGR+6.8%
Avg YoY Growth+6.9%
Median YoY Growth+10.3%
Current Streak3 quarters growth
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's total current assets?
- Regeneron Pharmaceuticals (REGN) reported total current assets of $18.21B in Q1 2026.
- How has Regeneron Pharmaceuticals's total current assets changed year-over-year?
- Regeneron Pharmaceuticals's total current assets increased by 3.6% year-over-year, from $17.57B to $18.21B.
- What is the long-term trend for Regeneron Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's total current assets has grown at a 13.0% compound annual growth rate (CAGR), from $9.78B to $18.02B.
- What does total current assets mean?
- Everything the company owns that can be turned into cash within a single year.